I405V polymorphism of the cholesteryl ester transfer protein (CETP) gene in young and very old people

Archives of Gerontology and Geriatrics

Volumn 43, Issue 2, 2006, Pages 213-221

  Vergani, Carlo ^a   Lucchi, Tiziano ^a   Caloni, Marianna ^a   Ceconi, Ieda ^a   Calabresi, Carmen ^a   Scurati, Silvia ^a   Arosio, Beatrice ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Atherosclerosis; CETP gene; Cholesteryl ester transfer protein (CETP); Lipoprotein metabolism; Longevity; Polymorphism I405V

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL ESTER TRANSFER PROTEIN; ISOLEUCINE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VALINE;

ADULT; AGED; ARTICLE; BIOASSAY; BLOOD VESSEL INJURY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DEVELOPMENTAL GENETICS; DISEASE ASSOCIATION; DNA DETERMINATION; DNA POLYMORPHISM; FEMALE; GENE; GENOTYPE; HUMAN; INCIDENCE; MALE; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGE FACTORS; AGED, 80 AND OVER; AGING; APOLIPOPROTEINS B; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; FEMALE; GENOTYPE; HUMANS; ISOLEUCINE; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; VALINE;

EID: 33747442794     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2005.10.008     Document Type: Article

References (44)

1. Agerholm-Larsen B., Nordestgaard B.G., Steffensen R., Jensen G., and Tybjaerg-Hansen A. Elevated HDL cholesterol is a factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene. Circulation 101 (2000) 1907-1912
2. Austin M.A., King M.C., Vranizan K.M., and Krauss R.M. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 82 (1990) 495-506
3. Barter P.J., and Rye K.A. Molecular mechanism of reverse cholesterol transport. Curr. Opin. Lipidol. 7 (1996) 82-87
4. Barter P.J., and Rye K.A. Cholesteryl ester transfer protein, high density lipoprotein and arterial disease. Curr. Opin. Lipidol. 12 (2001) 377-382
5. Barter P., Kastelein J., Nunn A., Hobbs R., and Future forum editorial board. High density lipoprotein (HDLs) and atherosclerosis; the unanswered questions. Atherosclerosis 168 (2003) 195-211
6. Barzilai N., Atzmon G., Schechter C., Schaefer E.J., Cupples A.L., Lipton R., Cheng S., and Shuldiner A.R. Unique lipoprotein phenotype and genotype associated with exceptional longevity. J. Am. Med. Assoc. 290 (2003) 2030-2040
7. Berard A.M., Foger B., Remaley A., Shamburek R., Vaisman B.L., Talley G., Paigen B., Hoyt Jr. R.F., Marcovina S., Brewer Jr. H.B., and Santamarina-Fojo S. High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase. Nat. Med. 3 (1997) 744-749
8. Boekholdt M.S., and Thompson J.F. Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease. J. Lipid Res. 44 (2003) 1080-1093
9. Boekholdt M.S., Kuivenhoven J.A., Kees Hoving G., Wouter Jukema J., Kastelein J.J.P., and Van Tol A. CETP gene variation: relation to lipid parameters and cardiovascular risk. Curr. Opin. Lipidol. 15 (2004) 393-398
10. Brewer Jr. H.B. Focus on high-density lipoproteins in reducing cardiovascular risk. Am. Heart J. 148 (2004) S14-S18
11. Brewer Jr. H.B., and Santamaria-Fojo S. New insights into the role of the adenosine triphosphate-binding cassette transporters in high-density lipoprotein metabolism and reverse cholesterol transport. Am. J. Cardiol. 91 (2003) 3E-11E
12. Brousseau M.E., Schaefer E.J., Wolfe M.L., Bloedon L.T., Digenio A.G., Clark R.W., Mancuso J.P., and Rader D.J. Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. N. Engl. J. Med. 350 (2004) 1505-1515
13. Cooper R.S. Gene-environment interactions and the etiology of common complex disease. Ann. Intern. Med. 139 (2003) 437-440
14. De Grooth G.J., Zerba K.E., Huang S.P., Tsuchihashi Z., Kirchgessner T., Belder R., Vishnupad P., Hu B., Klerkx A.H., Zwinderman A.H., Jukema J.W., Sacks F.M., Kastelein J.J., and Kuivenhoven J.A. The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy. J. Am. Coll. Cardiol. 43 (2004) 854-857
15. Drayna D., Jarnagin A.S., McLean J., Henzel W., Kohr W., Fielding C., and Lawn R. Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature 327 (1987) 632-634
16. Glomset J.A. The plasma lecithin: cholesterol acyltransferase reaction. J. Lipid Res. 9 (1968) 155-167
17. Glueck C.J., Fallat R.W., Millett F., Gartside P., Elston R.C., and Go R.C. Familial hyper-alpha-lipoproteinemia: studies in eighteen kindreds. Metabolism 24 (1975) 1243-1265
18. Gordon D.J., Probstfield J.L., Garrison R.J., Neaton J.D., Castelli W.P., Knoke J.D., Jacobs Jr. D.R., Bangdiwala S., and Tyroler H.A. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79 (1989) 8-15
19. Gotto Jr. A.M., and Brinton E.A. Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease. J. Am. Coll. Cardiol. 43 (2004) 717-724
20. Gudnason V., Kakko S., Nicaud V., Savolainen M.J., Kesäniemi Y.A., Tahva-nainen E., Humphries S., and On behalf of the EARS group. Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. Eur. J. Clin. Invest. 29 (1999) 116-128
21. Harris T.B. Cholesterol and health in old age: risk factor or risk marker?. J. Am. Geriatr. Soc. 52 (2004) 639-640
22. Hayden M.R., Clee S.M., Brooks-Wilson A., Genest Jr. J., Attie A., and Kastelein J.J. Cholesterol efflux regulatory protein, Tangier disease and familial high-density lipoprotein deficiency. Curr. Opin. Lipidol. 11 (2000) 117-123
23. Inazu A., Brown M.L., Hesler C.B., Agellon L.B., Koizumi J., Takata K., Maruhama Y., Mabuchi H., and Tall A.R. Increased high density lipoprotein caused by a common cholesteryl ester transfer protein gene mutation. N. Engl. J. Med. 323 (1990) 1234-1238
24. Inazu A., Koizumi J., and Mabuchi H. Cholesteryl ester transfer protein and atherosclerosis. Curr. Opin. Lipidol. 11 (2000) 389-396
25. Istituto Nazionale di Statistica, 2004. Roma (in Italian).
26. Karlamangla A.S., Singer B.H., Reuben D.B., and Seeman T.E. Increases in serum non-high-density lipoprotein cholesterol may be beneficial in some high-functioning older adults: MacArthur studies of successful aging. J. Am. Geriatr. Soc. 52 (2004) 487-494
27. Katzel L.I., and Goldberg A.P. Dyslipoproteinemia. In: Hazzard W.R., Blass J.P., Halter J.B., Ouslander J.G., and Tinetti M.E. (Eds). Principles of Geriatric Medicine and Gerontology. fifth ed. (2003), McGraw-Hill, New York 875-891
28. Knoblauch H., Bauerfeind A., Toliat M.R., Becker C., Luganskaja T., Gunther U.P., Rohde K., Schuster H., Junghans C., Luft F.C., Nurnberg P., and Reich J.G. Haplotypes and SNPs in 13 lipid-relevant genes explain most of the genetic variance in high-density lipoprotein and low-density lipoprotein cholesterol. Hum. Mol. Genet. 13 (2004) 993-1004
29. Kuivenhoven J.A., de Knijff P., Boer J.M., Smalheer H.A., Botma G.J., Seidell J.C., Kastelein J.J., and Pritchard P.H. Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 560-568
30. Kuivenhoven J.A., Wouter Ukema J., Zwinderman A.H., de Knijff P., McPherson R., Bruschke A.V.G., Lie K.I., and Kastelein J.J.P. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. N. Engl. J. Med. 338 (1998) 86-93
31. Lamarche B., Tchernof A., Moorjani S., Cantin B., Dagenais G.R., Lupien P.J., and Despres J.P. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 95 (1997) 69-75
32. Ljungquist B., Berg S., Lanke J., McClearn G.E., and Pedersen N.L. The effect of genetic factors for longevity: a comparison of identical and fraternal twins in the Swedish Twin Registry. J. Gerontol. A Biol. Sci. Med. Sci. 53 (1998) M441-M446
33. Merkel M., Eckel R.H., and Goldberg I.J. Lipoprotein lipase: genetics, lipid uptake, and regulation. J. Lipid Res. 43 (2002) 1997-2006
34. Miller S.A., Dykes D.D., and Polesky H.F.A. Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16 (1988) 1215
35. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), 2002. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106, 3143-3421.
36. Nofer J.R., Kehrel B., Fobker M., Levkau B., Assman G., and Eckardstein A. HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis 161 (2002) 1-16
37. Okamoto H., Yonemori F., Wakitani K., Minowa T., Maeda K., and Shinkai H. A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits. Nature 406 (2000) 203-207
38. Okumura K., Matsui H., Kamiya H., Saburi Y., Hayashi K., and Hayakawa T. Differential effect of two common polymorphism in the cholesteryl ester transfer protein gene on low-density lipoprotein particle size. Atherosclerosis 161 (2002) 425-431
39. Perret B., Mabile L., Martinez L., Terce F., Barbaras R., and Collet X. Hepatic lipase: structure/function relationship, synthesis, and regulation. J. Lipid Res. 43 (2002) 1163-1169
40. Scanu A.M. Lp(a) lipoprotein-coping with heterogeneity. N. Engl. J. Med. 349 (2003) 2089-2090
41. Smith Jr. S.C., Milani R.V., Arnett D.K., Crouse III J.R., McDermott M.M., Ridker P.M., Rosenson R.S., Taubert K.A., Wilson P.W., and American Heart Association. Atherosclerotic vascular disease conference writing group II: risk factor. Circulation 109 (2004) 2613-2616
42. Sniderman A.D., Furberg C.D., Keech A., Roeters van Lennep J.E., Frohlich J., Jungner I., and Walldius G. Apolipoproteins versus lipids as indices of coronary risk and as targets for statin. Lancet 361 (2003) 777-780
43. Tall A.R., Dammerman M., and Breslow J.L. Disorders of lipoprotein metabolism. In: Chien K.R. (Ed). Molecular Basis of Cardiovascular Disease: a Companion to Braunwald's Heart Disease (1999), W.B. Saunders, Philadelphia 413-427
44. Zhong S., Sharp D.S., Grove J.S., Bruce C., Yano K., Curb J.D., and Tall A.R. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J. Clin. Invest. 97 (1996) 2917-2923